Breaking News

OmniReliant Holdings Acquires Topical Pharmaceutical Patent

January 25, 2008

OmniReliant Holdings, Inc. of Tampa, FL has formally acquired the rights to a unique patented topical pharmaceutical product.

OmniReliant Holdings, Inc. of Tampa, FL has formally acquired the rights to a unique patented topical pharmaceutical product capable of delivering salicylic acid in a non-stick clear solid composition to treat acne. The company will use the patented product to compliment its patent pending warming foam acne treatment product.

According to the company, its lead scientists William Bess and Leonard Mackles, who conceived the product, have agreed to sell the patent and collaborate with OmniReliant Holdings, Inc. to bring the formula to the highly competitive acne treatment market.


blog comments powered by Disqus
  • What

    What's Next for the UK?

    Sarah Boumphrey, Euromonitor International||June 27, 2016
    Euromonitor weighs in on how Brexit could impact consumer product companies.

  • The Future of Innovation

    The Future of Innovation

    Nancy Jeffries, Contributing Editor||June 27, 2016
    Fashion Institute of Technology graduate students tackle a far-reaching topic for their Capstone project.

  • Henkel Grabs the Sun

    Henkel Grabs the Sun

    Ian Bell, Euromonitor International||June 24, 2016
    Euromonitor's Ian Bell on the impact the purchase will have on the US detergent industry.

  • Take Notice

    Take Notice

    Melissa Meisel , Associate Editor||June 1, 2016
    Packaging trends revolve around trendy artwork, eco-conscious materials—and portability is a plus too!

  • Virtual Reality

    Virtual Reality

    Christine Esposito, Associate Editor||June 1, 2016
    An update on nature-identical ingredients for cosmetics and personal care products.

  • Shiseido Advances in the US

    Shiseido Advances in the US

    Tom Branna, Editorial Director||June 1, 2016
    New facility in Windsor, NJ demonstrates its dedication to the US and other markets outside Japan.